Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2) Peptid
EGLN2
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle PHD1 (EGLN2) Produkte
- PHD1 (EGLN2) (Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- FWSDRRNPHE VKPAYATRYA ITVWYFDAKE RAAARDKYQL ASGQKGVQVP
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of EGLN2 antibody,
Alternative Names: EGLN2 control peptide, EGLN2 antibody Blocking Peptide, Anti-EGLN2 Blocking Peptide, EGL nine homolog 2, C. elegans Blocking Peptide, MGC93662 Blocking Peptide, MGC93666 Blocking Peptide, PHD-1 Blocking Peptide, EGLN2, EGLN-2, EGLN 2, EGLN-2 Blocking Peptide, EGLN 2 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- PHD1 (EGLN2) (Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2))
- Hintergrund
- HIF-prolyl hydroxylase 1, might be involved in hypoxic preconditioning.
- Molekulargewicht
- 45 kDa
-
Sie sind hier:
